Evidence map›Paper›PMID 31583576›Full record

ArticleEndocrine2019

Risk factors for vertebral fracture in primary hyperparathyroidism.

Minghao Liu, John Williams, Jennifer Kuo, James A Lee, Shonni J Silverberg, Msarcella D Walker

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Bone Disease in Primary Hyperparathyroidism.Journal of musculoskeletal & neuronal interactions · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Higher serum levels of a cathepsin K-generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Minghao LiuDivision of Endocrinology, Department of Medicine, Columbia University, 180 Fort Washington Avenue, New York, NY, 10032, USA.
John WilliamsDivision of Endocrinology, Department of Medicine, Columbia University, 180 Fort Washington Avenue, New York, NY, 10032, USA.
Jennifer KuoDepartment of Surgery, Columbia University, 180 Fort Washington Avenue, New York, NY, 10032, USA.
James A LeeDepartment of Surgery, Columbia University, 180 Fort Washington Avenue, New York, NY, 10032, USA.
Shonni J SilverbergDivision of Endocrinology, Department of Medicine, Columbia University, 180 Fort Washington Avenue, New York, NY, 10032, USA.
Msarcella D WalkerDivision of Endocrinology, Department of Medicine, Columbia University, 180 Fort Washington Avenue, New York, NY, 10032, USA. mad2037@columbia.edu.ORCID http://orcid.org/0000-0002-7205-6527
Columbia University · USColumbia University Irving Medical Center · US

Funding

Endocrine Fellows Foundation n/a
6 · The paper itself

Abstract

purposeScreening for vertebral fractures (VF) in primary hyperparathyroidism (PHPT) is recommended, but there are limited data regarding which patients are at greatest risk for VF. We evaluated risk factors for VF in PHPT.

methodsThis is a retrospective cross-sectional analysis of 117 participants with PHPT. We assessed Grades 2 and 3 VF by vertebral fracture assessment (VFA) and the association of VF with the trabecular bone score (TBS), other skeletal parameters and clinical risk factors. VFA was performed only in those who met National Osteoporosis Foundation criteria for VFA screening.

resultsT-scores were in the osteopenic range and TBS was degraded. Overall VF rate based on VFA or other imaging was 12.8%. Serum PTH, calcium and TBS were not associated with VF. Those with VF were older (p = 0.04), had worse renal function (p = 0.04), were more likely to have received osteoporosis treatment (p = 0.03), and tended to have had a prior fracture (p = 0.06). T-scores did not differ by fracture status at any skeletal site. Those with VF had nine times the odds of osteoporosis at the hip (95% CI 2.4-34.5), but this risk factor had low sensitivity (46.7%) for VF. Hip T-score < -2.6, Age > 78.6 years, and GFR < 58.8 ml/min/1.73 m

conclusionsIn PHPT, VF risk factors included older age, prior fracture, worse renal function and osteoporosis at the hip, but not osteoporosis at other sites, TBS or biochemical indices of PHPT. Since identified risk factors had low sensitivity and were generally inaccurate for categorizing those with VF, the data do not support limiting screening to PHPT patients with these specific VF risk factors.

Indexed as

AgedAged, 80 and overCross-Sectional StudiesFemaleHumansHyperparathyroidism, PrimaryLumbar VertebraeMaleMiddle AgedNew York CityRetrospective StudiesRisk FactorsSpinal FracturesPrevalencePrimary hyperparathyroidismTBSVertebral fractures

Identifiers

PMID31583576
OpenAlexW2978217550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.